Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Clinical trial NCT05650229 · RECRUITING
Trial details
- NCT number
- NCT05650229
- Sponsor
- Pharming Technologies B.V.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-13
- Primary completion
- 2027-10-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.